Nickel alendronate

Nickel alendronate

The title compound {sys-tematic name: bis(μ(2)-dihydrogen 4-aza-niumyl-1-hy-droxy-butane-1,1-di-phos-pho-n-ato)bis-[aqua-(dihydrogen 4-aza-nium-yl-1-hy-droxy-butane-1,1-diphospho-n-ato)nickel(II)] dihydrate}, [Ni(2)(C(4)H(12)NO(7)P(2))(4)(H(2)O)(2)]·2H(2)O, was synthesiized under hydro-thermal conditions. Its structure is isotypic with the Co(II) analogue. The crystal structure is built up from...

Alendronate Attenuates Eosinophilic Airway

Bisphosphonates (BPs) have been widely used to treat osteoporosis. They act by inhibiting farnesyl diphosphate synthase in the mevalonate pathway. This resembles the action of statins, whose immune-modulating effect has recently been highlighted. In contrast , the effect of BPs on immune responses has not been elucidated well. In this study, we examined the effect of alendronate (ALN), a nitrog...

Alendronate sodium and uveitis

Alendronate sodium (Fosamax®) is a bisphosphonate that acts as a specific inhibitor of osteoclast mediated bone resorption. Bisphosphonates are synthetic analogues of pyrophosphate that bind to hydroxyapatite. The Dutch Medicine Evaluation Board approved alendronate sodium10 mg in April 1996. This formulation is indicated for the treatment and prevention of osteoporosis in women after menopause...

Hypoparathyroidism unmasked by alendronate.

The case of an elderly woman is reported in whom alendronate, given for osteoporosis, led to severe hypocalcaemia a few days after starting the drug treatment. This was caused by the unmasking of previously unrecognised hypoparathyroidism.

Alendronate and male osteoporosis.